Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MARK A GOLDSMITH Insider Profile
4 Followers
MARK A GOLDSMITH, Director at Constellation Pharmaceuticals, holds 838.34K shares in Revolution Medicines (Ticker: RVMD), holds 89.86K shares in Constellation Pharmaceuticals (Ticker: CNST).
MARK A GOLDSMITH Constellation Pharmaceuticals (CNST)Director
Constellation Pharmaceuticals (CNST)
Director
Ranked #35,911 out of 97,944 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+4.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of MARK A GOLDSMITH's holdings
Insider Roles
President & CEO, Director
Roles that MARK A GOLDSMITH holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 21, 2021 - Sep 21, 2022
Return:+45.50%
The most profitable trade made by MARK A GOLDSMITH
MARK A GOLDSMITH's Trading History
Constellation Pharmaceuticals
Dec 28, 2020
―
Uninformative Sell
140.74K
$3.05M
Revolution Medicines
Jun 20, 2024
President & CEO, Director
Uninformative Sell
446.69K
$30.95M
List of latest transactions for each holding click on a transaction to see MARK A GOLDSMITH's performance on stock
You May Also Like
MARK A GOLDSMITH insider profile FAQ
What is the percentage of profitable transactions made by MARK A GOLDSMITH?
The percentage of profitable transactions made by MARK A GOLDSMITH is 50%.
What is the average return per transaction made by MARK A GOLDSMITH?
The average return per transaction made by MARK A GOLDSMITH is 4.80%.
What stocks does MARK A GOLDSMITH hold?
MARK A GOLDSMITH holds: CNST, RVMD stocks.
What was MARK A GOLDSMITH’s latest transaction?
MARK A GOLDSMITH latest transaction was an Uninformative Sell of $446.69K.
What was MARK A GOLDSMITH's most profitable transaction?
MARK A GOLDSMITH’s most profitable transaction was an Informative Sell of RVMD stock on September 21, 2021. The return on the trade was 45.50%.
What is MARK A GOLDSMITH's role in Constellation Pharmaceuticals?
MARK A GOLDSMITH's role in Constellation Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.